Hepatitis E News Today

1. Overall vaccine efficacy ranged from 83.1% to 86.6% during the 10-year period. 2. Detectable concentrations of antibodies persisted at the 8.5-year mark in Qindong. Evidence Rating Level: 1 (Excellent) Study Rundown: Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis worldwide. Currently, two recombinant HEV vaccines exist; however, little is known

1. Overall vaccine efficacy ranged from 83.1% to 86.6% during the 10-year period. 2. Detectable concentrations of antibodies persisted at the 8.5-year mark in Qindong. Evidence Rating Level: 1 (Excellent) Study Rundown: Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis worldwide. Currently, two recombinant HEV vaccines exist; however, little is known

Hepatitis E caused an estimated 44,000 deaths in 2015, accounting for 3.3% of the mortality caused by viral hepatitis.

While the hepatitis E virus causes tens of thousands of deaths each year, data suggest that a vaccine approved in China has long-term efficacy.

Researchers have identified genetic traces of hepatitis E viruses in almost 73 percent of wastewater samples from North-Rhine Westphalia.

Doctors Without Borders say 501 cases have been treated and majority casualties are women.

A combination therapy with multiple drugs is more effective than just one active compound. To begin with, at least.

The prevalence of the Hepatitis E virus (HEV) in the Portuguese wild boar population.

There are a large number of people who are detected with hepatitis A and E during the rainy season. Here are its causes along with treatment and prevention tips | Health

Unusual rains in the National Capital Region have led to a rise in diseases like Hepatitis A and E and eye flu. Doctor shares facts.